opentrade on 
↗
↗event5 outcomes
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
·Science and Technology·ends Jan 8, 2028vol cum
$10.2k
vol 24h
$0
outcomes
5
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before 2028
rank #1
United States
92¢
· 0.0pp
24h change
vol cum
$233
vol 24h
$0
spread
0.07
ends
Jan 8, 2028
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.
timeline
opened · Mar 24, 2026opencloses · Jan 8, 2028
prices over time · Before 2028 highlighted
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdatakalshiWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
before 202779¢· 0.0ppbefore April 202776¢· 0.0ppbefore December75¢· 0.0pp
+3 others
$0 24h · 6 markets
polymarketFDA approves Retatrutide this year?
yes11¢▼ 0.5pp
$80 24h · 1 market
Will AOH1996 be FDA approved before 2040?
yes40¢· 0.0pp
M0 24h · 1 market
kalshiWill the FDA approve any psychedelic substance for medical use this year?
yes24¢▲ 4.0pp
$2.9k 24h · 1 market
polymarketFDA approves Daraxonrasib this year?
yes71¢· 0.0pp
$0 24h · 1 market
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
yes26¢· 0.0pp
M0 24h · 1 market